M-END

Product NDC
12830-754
Requested package NDC
12830-754-30
11-digit product format
128300754
Labeler code
12830
Product ID
12830-754_efea1788-442f-8396-e053-2995a90a5cc4
Type
HUMAN OTC DRUG
Nonproprietary name
Codeine Phosphate, Phenylephrine Hydrochloride, Brompheniramine Maleate
Dosage form
LIQUID
Route
ORAL
Labeler
R.A. McNeil Company
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2008-11-11
Marketing end
0000-00-00
Substance
BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE
Active strength
1 mg/5mL; mg/5mL; mg/5mL
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], alpha-1 Adrenergic Agonist [EPC]
DEA schedule
CV
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage12830-75412830-754-30DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 13 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2022-08-30 03:57 UTC · source 2022-08-29IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
12830-754-122022-12-22M-END PE
12830-754-302022-12-22M-END PE
12830-754-122022-07-29M-END PE
12830-754-302022-07-29M-END PE

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BROMPHENIRAMINE MALEATEACTIVE INGREDIENTIXA7C9ZN03M-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
CODEINE PHOSPHATEACTIVE INGREDIENTGSL05Y1MN6M-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
BROMPHENIRAMINEACTIVE MOIETYH57G17P2FNM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
CODEINE ANHYDROUSACTIVE MOIETYUX6OWY2V7JM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
GLYCERININACTIVE INGREDIENTPDC6A3C0OXM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3M-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
SORBITOLINACTIVE INGREDIENT506T60A25RM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2
WATERINACTIVE INGREDIENT059QF0KO0RM-END PE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE) LIQUID [R.A. MCNEIL COMPANY]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
12830-754-301283007543030 mL in 1 BOTTLE (12830-754-30) 30 ml2014-12-190000-00-00NoNoCurrent